72.19.Z - Scientific research and development activities
20.59.Z - Manufacture of other chemical products, not elsewhere classified
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
70.22.Z - Head office activities and management consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | -88,4 | -116,3 | -31,6 |
EBITDA | -55,1 | -86,1 | -56,2 |
Short time liabilities | 13,5 | 7,7 | -42,8 |
Equity capital | 168,3 | 52 | -69,1 |
Operating profit (EBIT) | -88,4 | -115,4 | -30,6 |
Assets | 760,9 | 157,4 | -79,3 |
Net profit (loss) | -88,4 | -116,3 | -31,6 |
Cash | 678,9 | 9,4 | -98,6 |
Liabilities and provisions for liabilities | 592,6 | 105,4 | -82,2 |
Net income from sale | 0 | 134,9 | -∞ |
Working assets | 742,5 | 20,9 | -97,2 |
Depreciation | 33,3 | 29,3 | -11,9 |
% | % | p.p. | |
Profitability of capital | -52,5 | -223,7 | -171,2 |
Equity capital to total assets | 22,1 | 33 | 10,9 |
Gross profit margin | -86,2 | ||
EBITDA Margin | -63,8 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 21 | -2 147 483 627 |
Current financial liquidity indicator | 1.2528812885284424 | 0.1985207498073578 | -1,1 |
Net dept to EBITDA | 12.322214126586914 | 0.03493552282452583 | -12,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane